BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 11717152)

  • 1. Coronary vasodilation and improvement in endothelial dysfunction with endothelin ET(A) receptor blockade.
    Halcox JP; Nour KR; Zalos G; Quyyumi AA
    Circ Res; 2001 Nov; 89(11):969-76. PubMed ID: 11717152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous endothelin in human coronary vascular function: differential contribution of endothelin receptor types A and B.
    Halcox JP; Nour KR; Zalos G; Quyyumi AA
    Hypertension; 2007 May; 49(5):1134-41. PubMed ID: 17353514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin receptor blockade improves endothelial function in human internal mammary arteries.
    Verma S; Lovren F; Dumont AS; Mather KJ; Maitland A; Kieser TM; Kidd W; McNeill JH; Stewart DJ; Triggle CR; Anderson TJ
    Cardiovasc Res; 2001 Jan; 49(1):146-51. PubMed ID: 11121806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved endothelial function after endothelin receptor blockade in patients with systemic sclerosis.
    Cardillo C; Schinzari F; Melina D; Mores N; Bosello S; Peluso G; Zoli A; Ferraccioli G
    Arthritis Rheum; 2009 Jun; 60(6):1840-4. PubMed ID: 19479828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin-1 vasoconstriction and the age-related decline in endothelium-dependent vasodilatation in men.
    Westby CM; Weil BR; Greiner JJ; Stauffer BL; DeSouza CA
    Clin Sci (Lond); 2011 Jun; 120(11):485-91. PubMed ID: 21143196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension.
    Cardillo C; Campia U; Kilcoyne CM; Bryant MB; Panza JA
    Circulation; 2002 Jan; 105(4):452-6. PubMed ID: 11815427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regular aerobic exercise counteracts endothelial vasomotor dysfunction associated with insufficient sleep.
    Stockelman KA; Bain AR; Dow CA; Diehl KJ; Greiner JJ; Stauffer BL; DeSouza CA
    Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H1080-H1088. PubMed ID: 33416458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antagonists for endothelin ET(A) and ET(B) receptors on coronary endothelial and myocardial function after ischemia-reperfusion in anesthetized goats.
    Climent B; Fernández N; García-Villalón AL; Monge L; Sánchez A; Diéguez G
    Vascul Pharmacol; 2006 May; 44(5):384-90. PubMed ID: 16580265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective endothelin ETA and dual ET(A)/ET(B) receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery disease.
    Rafnsson A; Shemyakin A; Pernow J
    Life Sci; 2014 Nov; 118(2):435-9. PubMed ID: 24607773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis.
    Zeiher AM; Drexler H; Wollschläger H; Just H
    Circulation; 1991 Feb; 83(2):391-401. PubMed ID: 1991363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of endothelial function by endothelin antagonism in human saphenous vein conduits.
    Dumont AS; Lovren F; McNeill JH; Sutherland GR; Triggle CR; Anderson TJ; Verma S
    J Neurosurg; 2001 Feb; 94(2):281-6. PubMed ID: 11213966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin-1 is a key mediator of coronary vasoconstriction in patients with transplant coronary arteriosclerosis.
    Larose E; Behrendt D; Kinlay S; Selwyn AP; Ganz P; Fang JC
    Circ Heart Fail; 2009 Sep; 2(5):409-16. PubMed ID: 19808370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
    Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
    Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation.
    Quyyumi AA; Dakak N; Diodati JG; Gilligan DM; Panza JA; Cannon RO
    J Am Coll Cardiol; 1997 Nov; 30(5):1220-7. PubMed ID: 9350919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium.
    Zeiher AM; Drexler H; Wollschlaeger H; Saurbier B; Just H
    J Am Coll Cardiol; 1989 Nov; 14(5):1181-90. PubMed ID: 2808971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-A and -B antagonists protect myocardial and endothelial function after ischemia/reperfusion in a rat heart transplantation model.
    Szabó G; Fazekas L; Bährle S; MacDonald D; Stumpf N; Vahl CF; Hagl S
    Cardiovasc Res; 1998 Sep; 39(3):683-90. PubMed ID: 9861312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis.
    Helmy A; Jalan R; Newby DE; Johnston NR; Hayes PC; Webb DJ
    Hepatology; 2001 Apr; 33(4):826-31. PubMed ID: 11283846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
    Zhang Y; Oliver JR; Horowitz JD
    Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation.
    Ivy DD; Kinsella JP; Abman SH
    J Clin Invest; 1994 May; 93(5):2141-8. PubMed ID: 8182146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regular aerobic exercise reduces endothelin-1-mediated vasoconstrictor tone in overweight and obese adults.
    Dow CA; Stauffer BL; Brunjes DL; Greiner JJ; DeSouza CA
    Exp Physiol; 2017 Sep; 102(9):1133-1142. PubMed ID: 28635124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.